Actis Biologics

Rediff.com » News » Actis Biologics

News for Actis Biologics

Business

Drug firms go slow on overseas M&As

Outbound acquisitions by Indian drug companies slumped 67 per cent during the year as a global credit crunch squeezed liquidity. The less-than-anticipated results of a few big-ticket acquisitions......

Pharma firms eye small buys to stay fit

Dr Reddy's Laboratories, Nicholas Piramal and other Indian drug makers are relying on niche and smaller value, acquisition strategy for growth owing to global slowdown and failure of big-ticket......

Leela eyes stake in Actis Biologics

Leela Ventures, the hospitality and real estate group, is likely to enter biopharmaceuticals. The company is picking up a minority stake in Actis Biologics Private Ltd, the Indian subsidiary of the......

US firm in talks with Actis for cell technology

US biotech company Jennerex Biotherapeutics is in talks with Actis Biologics to co-develop and license out a novel cell technology VFF2. VFF2, a unique technology discovered by Actis Biologics......

Actis plans research arm, multiple JVs

US-based biopharmaceutical company Actis Biologics Inc is setting up its wholly owned subsidiary in India in a move to make the country a hub for its clinical research and developmental......

Rediff News

Actis Biologics

News for Actis Biologics

Drug firms go slow on overseas M&As

Pharma firms eye small buys to stay fit

Leela eyes stake in Actis Biologics

US firm in talks with Actis for cell technology

Actis plans research arm, multiple JVs

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS